VATS BIOTECH PRIVATE LIMITED is focused on developing and marketing affordable healthcare products. India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in the UK. Globally, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value. The domestic pharmaceutical industry includes a network of 3,000 drug companies and ~10,500 manufacturing units.
According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India’s domestic pharmaceutical market is estimated at US$ 42 billion in 2021 and likely to reach US$ 65 billion by 2024 and further expand to reach ~US$ 120-130 billion by 2030.
India’s drugs and pharmaceuticals exports stood at US$ 24.44 billion in FY21.
With these growing opportunities Vats Biotech is continuously focusing on how we can grow. At Vats, we strive to lead the way by aggressive penetration in all targeted markets through an accomplished business strategies over the coming years by a highly dedicated and skilled team members while maintaining a high priority to affordable and quality healthcare products.
Disclaimer: This information has been collected through secondary research and Vats Biotech Private Limited is not responsible for any errors in the same